NovoCure (NVCRN) Q3 2024 Earnings Report
MX:NVCRN Q3 2024 EPS Results
- Actual EPS
- -MXN 5.26
- Consensus EPS
- -MXN 6.28
- Beat/Miss
- Beat by +MXN 1.01
- One Year Ago EPS
- -MXN 8.64
MX:NVCRN Q3 2024 Revenue Results
- Actual Revenue
- MXN 2.91B
- Expected Revenue
- MXN 2.71B
- Beat/Miss
- Beat by +MXN 209.49M
- YoY Revenue Growth
- +21.81%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/30/2024
- Time
- Before Open
- Conference Call
- Wednesday, October 30, 2024
MX:NVCRN Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
MX:NVCRN Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVCRN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -4.15- | -4.13 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -4.42-1.69 | -6.2 | 72.73% (+4.51) | |
| Jul 23, 2026 | 2026 (Q2) | -6.24-2.44 | -6.77 | 63.89% (+4.32) | |
| Apr 30, 2026 | 2026 (Q1) | -9.62-11.65 | -5.83 | -100.00% (-5.83) | |
| Feb 26, 2026 | 2025 (Q4) | -7.72-4.13 | -11.46 | 63.93% (+7.33) | |
| Oct 30, 2025 | 2025 (Q3) | -7.89-6.20 | -5.26 | -17.86% (-0.94) | |
| Jul 24, 2025 | 2025 (Q2) | -7.22-6.77 | -5.83 | -16.13% (-0.94) | |
| Apr 24, 2025 | 2025 (Q1) | -8.72-5.83 | -6.77 | 13.89% (+0.94) | |
| Feb 27, 2025 | 2024 (Q4) | -6.46-11.46 | -8.46 | -35.56% (-3.01) | |
| Oct 30, 2024 | 2024 (Q3) | -6.28-5.26 | -8.64 | 39.13% (+3.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
